Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial
Dina Kao, Karen Wong, Rose Franz, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 4, pp. 282-291
Closed Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Microbiota-directed biotherapeutics: considerations for quality and functional assessment
Emily E.F. Fekete, Daniel Figeys, Xu Zhang
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details
Lea Monday, Glenn Tillotson, Teena Chopra
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 623-639
Open Access | Times Cited: 5
Assessing live microbial therapeutic transmission
Jeremiah J. Faith
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Precision microbial regulation: Strategies for modulating GIT microbiota for host health
Zhong Pei, Qin Li, Yanmei Zhang, et al.
iMetaOmics. (2025)
Open Access
Validation methods for encapsulated faecal microbiota transplantation: a scoping review
Nina Rågård, Simon Mark Dahl Baunwall, Sara Ellegaard Paaske, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Fecal microbiota transplantation-current perspective on human health
Zixuan Cao, Tingting Gao, Ousman Bajinka, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Translating Microbiome Research From and To the Clinic
Zhenrun J. Zhang, Christopher Lehmann, Cody G. Cole, et al.
Annual Review of Microbiology (2022) Vol. 76, Iss. 1, pp. 435-460
Open Access | Times Cited: 22
Clostridioides difficile Infection: Landscape and Microbiome Therapeutics.
Brent J. Gawey, Sahil Khanna
PubMed (2023) Vol. 19, Iss. 6, pp. 319-328
Closed Access | Times Cited: 11
Bile acids impact the microbiota, host, and C. difficile dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics
Arthur S. McMillan, Casey M. Theriot
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Effects of Lyophilized Fecal Filtrate Compared with Lyophilized Donor Stool for Preventing Recurrent Clostridioides Difficile Infection: A Multi-Center, Randomized, Double-Blinded Trial
Dina Kao, Karen Wong, Christine Lee, et al.
(2025)
Closed Access
Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
Avnish Sandhu, Teena Chopra
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 25
Current clinical translation of microbiome medicines
Laura E. McCoubrey, Moe Elbadawi, Abdul W. Basit
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 4, pp. 281-292
Open Access | Times Cited: 16
The Relationship Between the Microbiome and Antimicrobial Resistance
Nguyen T. Q. Nhu, Vincent B. Young
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_6, pp. S479-S486
Open Access | Times Cited: 10
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies
Parul Berry, Sahil Khanna
BioDrugs (2023) Vol. 37, Iss. 6, pp. 757-773
Closed Access | Times Cited: 8
Microbes as medicine
Brendan A. Daisley, Emma Allen‐Vercoe
Annals of the New York Academy of Sciences (2024) Vol. 1541, Iss. 1, pp. 63-82
Open Access | Times Cited: 2
Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics
Shuang Li, Yi-Xuan Zhang
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 3, pp. 371-384
Closed Access | Times Cited: 6
A microbial consortium alters intestinal Pseudomonadota and antimicrobial resistance genes in individuals with recurrent Clostridioides difficile infection
Ashley M. Rooney, Kyla Cochrane, Stephanie Fedsin, et al.
mBio (2023)
Open Access | Times Cited: 6
Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards
Nur Masirah M. Zain, Daniëlle ter Linden, Andrew Lilley, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 324-331
Open Access | Times Cited: 10
Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2
Devvrat Yadav, Sahil Khanna
Therapeutic Advances in Gastroenterology (2021) Vol. 14, pp. 175628482110096-175628482110096
Open Access | Times Cited: 14
Principles and Terminology for Host–Microbiome–Drug Interactions
Alya Heirali, Shirin Moossavi, Marie‐Claire Arrieta, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 4
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review
Sarah B. Doernberg, César A. Arias, Deena R. Altman, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_4, pp. S295-S304
Closed Access | Times Cited: 4
Fighting against Clostridioides difficile infection: Current medications
Min Quan, Xiaoxia Zhang, Qingqing Fang, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 1, pp. 107198-107198
Closed Access | Times Cited: 1
Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection
Patricia P. Bloom, Vincent B. Young
Expert Opinion on Biological Therapy (2022) Vol. 23, Iss. 1, pp. 89-101
Closed Access | Times Cited: 7
Patient Experiences with Clostridioides difficile Infection and Its Treatment: A Systematic Literature Review
Edward P. Armstrong, Daniel C. Malone, Duska M. Franic, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 7, pp. 1775-1795
Open Access | Times Cited: 3
SARS-CoV-2–Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals
Yanling Liu, Patrick Budylowski, Shilan Dong, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 10, pp. 2581-2588
Open Access | Times Cited: 8

Scroll to top